» Articles » PMID: 38415056

Metabolic Clues to Aging: Exploring the Role of Circulating Metabolites in Frailty, Sarcopenia and Vascular Aging Related Traits and Diseases

Overview
Journal Front Genet
Date 2024 Feb 28
PMID 38415056
Authors
Affiliations
Soon will be listed here.
Abstract

Physical weakness and cardiovascular risk increase significantly with age, but the underlying biological mechanisms remain largely unknown. This study aims to reveal the causal effect of circulating metabolites on frailty, sarcopenia and vascular aging related traits and diseases through a two-sample Mendelian Randomization (MR) analysis. Exposures were 486 metabolites analyzed in a genome-wide association study (GWAS), while outcomes included frailty, sarcopenia, arterial stiffness, atherosclerosis, peripheral vascular disease (PAD) and aortic aneurysm. Primary causal estimates were calculated using the inverse-variance weighted (IVW) method. Methods including MR Egger, weighted median, Q-test, and leave-one-out analysis were used for the sensitive analysis. A total of 125 suggestive causative associations between metabolites and outcomes were identified. Seven strong causal links were ultimately identified between six metabolites (kynurenine, pentadecanoate (15:0), 1-arachidonoylglycerophosphocholine, androsterone sulfate, glycine and mannose) and three diseases (sarcopenia, PAD and atherosclerosis). Besides, metabolic pathway analysis identified 13 significant metabolic pathways in 6 age-related diseases. Furthermore, the metabolite-gene interaction networks were constructed. Our research suggested new evidence of the relationship between identified metabolites and 6 age-related diseases, which may hold promise as valuable biomarkers.

Citing Articles

Causal Relationship Between Circulating Metabolites and Sarcopenia-Related Traits: A Mendelian Randomization and Experimental Study.

Qi W, Mao X, Mei Z, Zhu L, Shao Y, Ge G Food Sci Nutr. 2025; 13(1):e4624.

PMID: 39803274 PMC: 11717068. DOI: 10.1002/fsn3.4624.


Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions.

de Lima E, Tanaka M, Lamas C, Quesada K, Detregiachi C, Cressoni Araujo A Biomedicines. 2024; 12(9).

PMID: 39335609 PMC: 11428869. DOI: 10.3390/biomedicines12092096.


Lumican Is Both a Novel Risk Factor and Potential Plasma Biomarker for Vascular Aging, Capable of Promoting Vascular Smooth Cells Senescence Through Interacting With Integrin α2β1.

Luo M, Yan D, Huang Y, Ji T, Luo P, Yang Z J Gerontol A Biol Sci Med Sci. 2024; 80(1.

PMID: 39190316 PMC: 11664257. DOI: 10.1093/gerona/glae214.

References
1.
Gao Y, Hong Y, Huang L, Zheng S, Zhang H, Wang S . β2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function. Cell. 2023; 186(5):1026-1038.e20. DOI: 10.1016/j.cell.2023.01.021. View

2.
Lusis A . Atherosclerosis. Nature. 2000; 407(6801):233-41. PMC: 2826222. DOI: 10.1038/35025203. View

3.
Paapstel K, Kals J . Metabolomics of Arterial Stiffness. Metabolites. 2022; 12(5). PMC: 9146333. DOI: 10.3390/metabo12050370. View

4.
Muradi A, Jasirwan C, Simanjuntak C, Pratama D, Suhartono R, Darwis P . The Correlation of Short-Chain Fatty Acids with Peripheral Arterial Disease in Diabetes Mellitus Patients. Life (Basel). 2022; 12(10). PMC: 9605079. DOI: 10.3390/life12101464. View

5.
Gaspar R, Halmi D, Demjan V, Berkecz R, Pipicz M, Csont T . Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease. Front Immunol. 2022; 12:768560. PMC: 8861075. DOI: 10.3389/fimmu.2021.768560. View